THE Therapeutic Goods Administration (TGA) has approved six new generic or biosimilar medicines during Dec 2018.
Generics are nitrofurantoin from Micro Labs, dexmedetomidine injection from Fresenius Kabi, levetiracetam from AdiraMedica, Tenofovir disoproxil fumarate from Hetero, Risperidone by Boucher & Muir and biosimilar trastuzumab by Alphapharm - see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Mar 19
